Charter Oak Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Charter Oak Capital Management, LLC
- $1.27 Billion
- Q4 2025
A detailed history of Charter Oak Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Charter Oak Capital Management, LLC holds 958 shares of REGN stock, worth $664,373. This represents 0.05% of its overall portfolio holdings.
Number of Shares
958Holding current value
$664,373% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,508Shares Held
86.6MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...